net dbt
climb growth ramp still remain
walgreen sign increment improv reiter outlook
intern step taken drive better profit on-going pressur
challeng stunt recent growth improv compstore rx stood
benefit eas comp store optim push although lost
market share bit concern meanwhil on-going oper expens leverag
appear place although serv off-set gross margin pressur
compani continu see industry-wid phenomenon appear
abat quarter didnt signific downsid surpris flat
outlook last still remain question visibl
better ebit perform full color come next earn call
final long believ meaning transact quicker way
reboot growth right strateg fit read manag commentari
suggest signific transact like time soon wba partnership
model drive increment contribut time enough lead
reboot ep growth result reiter under-perform rate
maintain po equat price-to-earnings
increas ep reduc ep
outlook driven continu gm pressur alreadi
incorpor on-going cost reduct busi optim
healthi amount capit deploy
upcom event catalyst
key focu investor gain increment comfort around reimburs
pressur head addit commentari around financi contribut
recent struck partnership increas labcorp roll-out
increas deliveri biggest nt opportun well view on-going store
ration final focu capit deploy updat includ
balanc vs buyback commentari suggest less like
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
walgreen follow complet rite
aid store acquisit largest global
pharmaci nearli store us
alon compani also oper intern
pharmaci busi primarili compos
boot pharmaci unit kingdom
allianc healthcar intern wholesal
distributor pharmaceut medic
product europ walgreen headquart
under-perform rate predic
pressur competit dynam
potenti increment competit
amazon small step market core
profit dollar growth slow think limit
visibl creat challeng near-term
stock perform view range-bound
last quarter tough pleas improv
expect provid signific fund technolog upgrad
work acceler cost manag program adjust busi
compet chang market
contribut buy-back contribut tax
adjust sg us retail pharmaci decreas y-o-i
adjust oper incom includ impact invest
market share y-o-i due store optim program
tobacco headwind us retail cough cold flu help
uk wholesal busi aid custom contract chang aid growth
ytd oper cash flow impact headwind
institut program reduc pharmaci cost fill
began locat store ration boot uk press report previous
store base expect revenu declin
review us real estat footprint acceler pace chang us includ
cloud roll-out remain pace also optim addit
share repurchas
full year tax rate vs
store benefit becom headwind due store
done store closur
store convers done expect finish end
sourc benefit aid offset reimburs
increment benefit reduc still contributor
explor partnership wide rang parti push improv hc servic
capabl vs tri establish servic
interest overpay complet larg transact
complac pressur face
potenti evalu store within store partnership
open partnership drive better volum
narrow network opportun
like normal year
time benefit
payer contract
real estat save
retire medic
expect margin improv underli basi next
clarif real estat comment
normal cours busi vs someth signific
think margin perform
start see improv gm trend
think
dont want get far ahead
start give comprehens guidanc around
oper piec
focu suppli chain improv
halfway chang current suppli chain system
see differ vs market low-singl digit deflat
market pressur uk pharmaci busi
convinc underfund weigh busi
global perspect opportun help
pharmaci market
see store close plenti other on-going pressur
also strongli believ local market presenc includ hc
list new potenti partner work
partnership work
pull-through food
get better
bit better procur benefit
stabil top-lin margin improv
price object base ep multipl
five-year averag absolut basi around discount five-year
averag reflect view walgreen core retail pharmaci busi long-
term structur pressur must diversifi stabl busi line improv
upsid risk better expect gener save new partnership
healthcar area labcorp etc support long-
term growth addit volum econdisc/rit aid contribut
addit new partnership faster expect growth prime therapeut
relationship downsid risk po on-going price reimburs pressur
higher prescript attrit part relationship integr risk
risk amazon anoth disrupt forc enter suppli chain market
lack available/app attract capit deploy opportun
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
